Literature DB >> 31807898

Multi-center analysis of intraocular biopsy technique and outcomes for uveal melanoma: Ocular Oncology Study Consortium report 4.

Michael I Seider1,2,3, Duncan E Berry3,4, Amy C Schefler5, Miguel Materin3, Sandra Stinnett3, Prithvi Mruthyunjaya6,7,8.   

Abstract

PURPOSE: To investigate the relationship between surgical approach for intraocular tumor biopsy of uveal melanoma and tumor morphologic features such as size and intraocular location and the effect of these variables on diagnostic yield and biopsy outcome.
METHODS: Consecutive patients from nine Ocular Oncology centers with uveal melanoma (UM) undergoing tumor biopsy immediately preceding I125 plaque brachytherapy with tissue sent for gene expression profiling (GEP) testing were reviewed retrospectively.
RESULTS: Three hundred sixty patients were included (50% men, mean age 60.2 years). Overall biopsy yield was 99% and 83% for GEP and cytopathology, respectively. Surgeon choice of biopsy approach (trans-vitreal vs. trans-scleral) was found to associate with both tumor location and tumor thickness. A trans-scleral rather than trans-vitreal approach was used more commonly for anteriorly located tumors (92% vs. 38% of posterior tumors, p < 0.001) and thicker tumors (86% vs. 55% of thin tumors, p < 0.001). When performing trans-vitreal biopsies, ocular oncologists with previous vitreoretinal surgery fellowship training were more likely to use wide-field surgical viewing systems, compared with indirect ophthalmoscopy (82.6% vs. 20.6%, p < 0.001). Surgical complications were rare and occurred more frequently with trans-vitreal biopsies (3.6% vs. 0.46%, p = 0.046).
CONCLUSIONS: In this multi-center analysis of UM tumor biopsy, surgical yield was high for obtaining tumor tissue for GEP and cytopathology analysis with both trans-scleral and trans-vitreal techniques. Fellowship-trained ocular oncologists' preferred intraocular biopsy techniques associated strongly with tumor location, tumor thickness, and fellowship training of the surgeon. Short-term complication rates were low.

Entities:  

Keywords:  Oncology; Ophthalmology

Mesh:

Year:  2019        PMID: 31807898      PMCID: PMC7738203          DOI: 10.1007/s00417-019-04531-8

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  16 in total

1.  Extraocular seeding of choroidal melanoma after a transretinal biopsy with a 25-gauge vitrector.

Authors:  Vignesh Raja; Andrea Russo; Sarah Coupland; Carl Groenewald; Bertil Damato
Journal:  Retin Cases Brief Rep       Date:  2011

Review 2.  MOLECULAR PROGNOSTICS FOR UVEAL MELANOMA.

Authors:  Michael I Seider; Prithvi Mruthyunjaya
Journal:  Retina       Date:  2018-02       Impact factor: 4.256

3.  Yield, Techniques, and Complications of Transvitreal and Transscleral Biopsies in Small Uveal Melanoma.

Authors:  Ryan Sangwoo Kim; Patricia Chevez-Barrios; Mukul Divatia; Maria Eugenia Bretana; Bin Teh; Amy Claire Schefler
Journal:  JAMA Ophthalmol       Date:  2018-05-01       Impact factor: 7.389

Review 4.  CHOROIDAL TUMOR BIOPSY: A Review of the Current State and a Glance Into Future Techniques.

Authors:  Avni P Finn; Miguel A Materin; Prithvi Mruthyunjaya
Journal:  Retina       Date:  2018-09       Impact factor: 4.256

5.  Frequency and implications of discordant gene expression profile class in posterior uveal melanomas sampled by fine needle aspiration biopsy.

Authors:  James J Augsburger; Zélia M Corrêa; Bret D Augsburger
Journal:  Am J Ophthalmol       Date:  2014-11-05       Impact factor: 5.258

6.  Association between Tumor Regression Rate and Gene Expression Profile after Iodine 125 Plaque Radiotherapy for Uveal Melanoma.

Authors:  Prithvi Mruthyunjaya; Michael I Seider; Sandra Stinnett; Amy Schefler
Journal:  Ophthalmology       Date:  2017-05-23       Impact factor: 12.079

7.  Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma.

Authors:  Michael D Onken; Lori A Worley; Devron H Char; James J Augsburger; Zelia M Correa; Eric Nudleman; Thomas M Aaberg; Michael M Altaweel; David S Bardenstein; Paul T Finger; Brenda L Gallie; George J Harocopos; Peter G Hovland; Hugh D McGowan; Tatyana Milman; Prithvi Mruthyunjaya; E Rand Simpson; Morton E Smith; David J Wilson; William J Wirostko; J William Harbour
Journal:  Ophthalmology       Date:  2012-04-21       Impact factor: 12.079

Review 8.  Molecular pathology of uveal melanoma.

Authors:  S E Coupland; S L Lake; M Zeschnigk; B E Damato
Journal:  Eye (Lond)       Date:  2012-12-07       Impact factor: 3.775

9.  EXTRAOCULAR EXTENSION OF CILIOCHOROIDAL MELANOMA AFTER TRANSSCLERAL FINE-NEEDLE ASPIRATION BIOPSY.

Authors:  Arman Mashayekhi; Renelle P Lim; Carol L Shields; Ralph C Eagle; Jerry A Shields
Journal:  Retin Cases Brief Rep       Date:  2016

10.  Intraoperative 4-Dimensional Microscope-Integrated Optical Coherence Tomography-Guided 27-Gauge Transvitreal Choroidal Biopsy for Choroidal Melanoma.

Authors:  Dilraj S Grewal; Paramjit K Bhullar; Neel D Pasricha; Oscar M Carrasco-Zevallos; Christian Viehland; Brenton Keller; Liango Shen; Joseph A Izatt; Anthony N Kuo; Cynthia A Toth; Prithvi Mruthyunjaya
Journal:  Retina       Date:  2017-04       Impact factor: 4.256

View more
  4 in total

Review 1.  Choroidal biopsies; a review and optimised approach.

Authors:  R N Hussain; B Damato; H Heimann
Journal:  Eye (Lond)       Date:  2022-08-08       Impact factor: 4.456

2.  Novel Guarded Needle Trans-Scleral Biopsy for Uveal Melanoma: A Pilot Study.

Authors:  Abtin Shahlaee; Musa Abdelaziz; Michael I Seider
Journal:  Ocul Oncol Pathol       Date:  2021-06-02

3.  Displacement of submacular hemorrhage with intravitreal tissue plasminogen activator following 27 gauge transvitreal fine needle aspiration biopsy for choroidal melanoma.

Authors:  Ramsudha Narala; Zachary Bodnar; Prithvi Mruthyunjaya
Journal:  Am J Ophthalmol Case Rep       Date:  2022-01-28

4.  Ultra-low dose external beam radiotherapy for presumed choroidal lymphoma: a case report.

Authors:  Jeremy P M Flanagan; Michael Ng; Awet Z Kibrom; Robin J A Filshie; Richard J Stawell; Roderick F O'Day
Journal:  J Ophthalmic Inflamm Infect       Date:  2022-03-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.